Effect of Baseline CT Scan Appearance and Time to Recanalization on Clinical Outcomes in Endovascular Thrombectomy of Acute Ischemic Strokes

被引:132
作者
Goyal, Mayank [1 ,2 ]
Menon, Bijoy K. [1 ]
Coutts, Shelagh B. [1 ,2 ]
Hill, Michael D. [1 ,2 ,3 ,4 ]
Demchuk, Andrew M. [1 ,2 ]
机构
[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[2] Univ Calgary, Dept Radiol, Calgary, AB, Canada
[3] Univ Calgary, Dept Med, Calgary, AB, Canada
[4] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
关键词
injections; intra-arterial; numerical data; physiopathology; statistics; stroke; treatment outcome; TISSUE-PLASMINOGEN-ACTIVATOR; THROMBOLYSIS; TRIAL; PROUROKINASE; REPERFUSION; ALTEPLASE; DIFFUSION; PREDICTS; SAFETY; MR;
D O I
10.1161/STROKEAHA.110.594481
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The Penumbra Pivotal Stroke Trial reported a 25% good outcome (modified Rankin scale score <= 2) despite an 81% recanalization rate. We evaluated the association of a favorable initial noncontrast CT and a short time to recanalization in predicting good outcome. Methods-Data were from the Penumbra Pivotal Stroke Trial. Baseline scans were evaluated by 2 experienced readers blinded to outcomes using ASPECTS. ASPECTS scores were dichotomized into >7 and <= 7 for primary analysis. Data on degree of recanalization based on thrombolysis in myocardial infarction scores, stroke onset to recanalization, and CT to recanalization times were obtained. Primary outcome was modified Rankin scale score <= 2 at 3 months. Results-Median baseline NIHSS was 18 (range, 8-34) and median baseline ASPECTS score was 6 (range, 0-10); 81.2% achieved recanalization (thrombolysis in myocardial infarction, 2-3) and (27.7%) achieved good outcome. Good outcome was significantly higher in the ASPECTS score >7 group when compared to the ASPECTS score <= 7 group (50% vs 15%; RR, 3.3; 95% CI, 1.6-6.8; P = 0.0001). No patient with an ASPECTS score <= 4 (n = 28) or without recanalization (n = 16) had a good outcome. There was an interaction between baseline ASPECTS score (>7 and <= 7) and onset to recanalization time (<= 300 minutes and >300 minutes) in predicting good outcome (P = 0.06). Conclusion-Patients with baseline CT ASPECTS score <= 4 do not benefit from recanalization. Fast recanalization may benefit patients with evident damage on the CT scan (ASPECTS score >4). Overall, patients benefit the most with early recanalization and a favorable baseline CT scan (ASPECTS score >7). (Stroke. 2011;42:93-97.)
引用
收藏
页码:93 / 97
页数:5
相关论文
共 28 条
[1]   Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study [J].
Albers, Gregory W. ;
Thijs, Vincent N. ;
Wechsle, Lawrence ;
Kemp, Stephanie ;
Schlaug, Gottfried ;
Skalabrin, Elaine ;
Bammer, Roland ;
Kakuda, Wataru ;
Lansberg, Maarten G. ;
Shuaib, Ashfaq ;
Coplin, William ;
Hamilton, Scott ;
Moseley, Michael ;
Marks, Michael P. .
ANNALS OF NEUROLOGY, 2006, 60 (05) :508-517
[2]   Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy [J].
Barber, PA ;
Demchuk, AM ;
Zhang, JJ ;
Buchan, AM .
LANCET, 2000, 355 (9216) :1670-1674
[4]   The interventional management of stroke (IMS) II study [J].
Broderick, Joseph P. .
STROKE, 2007, 38 (07) :2127-2135
[5]   Generalized efficacy of t-PA for acute stroke - Subgroup analysis of the NINDS t-PA stroke trial [J].
Brott, T ;
Broderick, J ;
Kothari, R ;
ODonoghue, M ;
Barsan, W ;
Tomsick, T ;
Spilker, J ;
Miller, R ;
Sauerbeck, L ;
Farrell, J ;
Kelly, J ;
Perkins, T ;
Miller, R ;
McDonald, T ;
Rorick, M ;
Hickey, C ;
Armitage, J ;
Perry, C ;
Thalinger, K ;
Rhude, R ;
Schill, J ;
Becker, PS ;
Heath, RS ;
Adams, D ;
Reed, R ;
Klei, M ;
Hughes, A ;
Anthony, J ;
Baudendistel, D ;
Zadicoff, C ;
Rymer, M ;
Bettinger, I ;
Laubinger, P ;
Schmerler, M ;
Meiros, G ;
Lyden, P ;
Dunford, J ;
Zivin, J ;
Rapp, K ;
Babcock, T ;
Daum, P ;
Persona, D ;
Brody, M ;
Jackson, C ;
Lewis, S ;
Liss, J ;
Mahdavi, Z ;
Rothrock, J ;
Tom, T ;
Zweifler, R .
STROKE, 1997, 28 (11) :2119-2125
[6]   THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE [J].
CHESEBRO, JH ;
KNATTERUD, G ;
ROBERTS, R ;
BORER, J ;
COHEN, LS ;
DALEN, J ;
DODGE, HT ;
FRANCIS, CK ;
HILLIS, D ;
LUDBROOK, P ;
MARKIS, JE ;
MUELLER, H ;
PASSAMANI, ER ;
POWERS, ER ;
RAO, AK ;
ROBERTSON, T ;
ROSS, A ;
RYAN, TJ ;
SOBEL, BE ;
WILLERSON, J ;
WILLIAMS, DO ;
ZARET, BL ;
BRAUNWALD, E .
CIRCULATION, 1987, 76 (01) :142-154
[7]   Recurrent Events in Transient Ischemic Attack and Minor Stroke Response [J].
Coutts, Shelagh B. ;
Hill, Michael D. ;
Demchuk, Andrew M. .
STROKE, 2009, 40 (02) :E34-E34
[8]   Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial [J].
Davis, Stephen M. ;
Donnan, Geoffrey A. ;
Parsons, Mark W. ;
Levi, Christopher ;
Butcher, Kenneth S. ;
Peeters, Andre ;
Barber, P. Alan ;
Bladin, Christopher ;
De Silva, Deidre A. ;
Byrnes, Graham ;
Chalk, Jonathan B. ;
Fink, John N. ;
Kimber, Thomas E. ;
Schultz, David ;
Hand, Peter J. ;
Frayne, Judith ;
Hankey, Graeme ;
Muir, Keith ;
Gerraty, Richard ;
Tress, Brian M. ;
Desmond, Patricia M. .
LANCET NEUROLOGY, 2008, 7 (04) :299-309
[9]   RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE THROMBOTIC AND EMBOLIC STROKE [J].
DELZOPPO, GJ ;
POECK, K ;
PESSIN, MS ;
WOLPERT, SM ;
FURLAN, AJ ;
FERBERT, A ;
ALBERTS, MJ ;
ZIVIN, JA ;
WECHSLER, L ;
BUSSE, O ;
GREENLEE, R ;
BRASS, L ;
MOHR, JP ;
FELDMANN, E ;
HACKE, W ;
KASE, CS ;
BILLER, J ;
GRESS, D ;
OTIS, SM .
ANNALS OF NEUROLOGY, 1992, 32 (01) :78-86
[10]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011